Compare AZN & PANW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AZN | PANW |
|---|---|---|
| Founded | 1992 | 2005 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer peripheral equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 250.7B | 270.4B |
| IPO Year | 1995 | 2012 |
| Metric | AZN | PANW |
|---|---|---|
| Price | $161.85 | $375.09 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 39 |
| Target Price | N/A | ★ $216.28 |
| AVG Volume (30 Days) | 3.1M | ★ 5.5M |
| Earning Date | 04-29-2026 | 05-19-2026 |
| Dividend Yield | ★ 1.73% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.40 |
| Revenue | N/A | ★ $2,273,100,000.00 |
| Revenue This Year | $10.34 | $24.93 |
| Revenue Next Year | $6.43 | $19.97 |
| P/E Ratio | ★ $31.91 | $418.54 |
| Revenue Growth | N/A | ★ 29.04 |
| 52 Week Low | $72.90 | $139.57 |
| 52 Week High | $212.71 | $398.88 |
| Indicator | AZN | PANW |
|---|---|---|
| Relative Strength Index (RSI) | 51.03 | 49.27 |
| Support Level | $153.97 | $314.96 |
| Resistance Level | $165.74 | $374.77 |
| Average True Range (ATR) | 2.78 | 16.35 |
| MACD | 0.16 | -2.87 |
| Stochastic Oscillator | 52.53 | 37.27 |
A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.
Palo Alto Networks is a platform-based cybersecurity vendor with product offerings covering network security, cloud security, and security operations. The California-based firm has more than 80,000 enterprise customers across the world, including more than three-fourths of the Global 2000.